358 related articles for article (PubMed ID: 17924986)
41. [Vitamin K1 and C metabolism in uremia during hemodialysis].
Bakaev VV; Khomenko VF
Urol Nefrol (Mosk); 1991; (1):40-3. PubMed ID: 1858205
[TBL] [Abstract][Full Text] [Related]
42. The Evolving Patterns of Uremia: Unmet Clinical Needs in Dialysis.
Yu X
Contrib Nephrol; 2017; 191():1-7. PubMed ID: 28910786
[TBL] [Abstract][Full Text] [Related]
43. Development of continuous implantable renal replacement: past and future.
Fissell WH; Fleischman AJ; Humes HD; Roy S
Transl Res; 2007 Dec; 150(6):327-36. PubMed ID: 18022594
[TBL] [Abstract][Full Text] [Related]
44. Flow distribution analysis by helical scanning in polysulfone hemodialyzers: effects of fiber structure and design on flow patterns and solute clearances.
Ronco C; Levin N; Brendolan A; Nalesso F; Cruz D; Ocampo C; Kuang D; Bonello M; De Cal M; Corradi V; Ricci Z
Hemodial Int; 2006 Oct; 10(4):380-8. PubMed ID: 17014516
[TBL] [Abstract][Full Text] [Related]
45. The optimal timing of hemoperfusion component in combined hemodialysis-hemoperfusion treatment for uremic toxins removal.
Li J; Li D; Xu Y; Wang A; Xu C; Yu C
Ren Fail; 2015 Feb; 37(1):103-7. PubMed ID: 25421427
[TBL] [Abstract][Full Text] [Related]
46. Avoiding harm and achieving optimal dialysis outcomes--the dialysate component.
Spiegel DM
Adv Chronic Kidney Dis; 2012 May; 19(3):166-70. PubMed ID: 22578676
[TBL] [Abstract][Full Text] [Related]
47. Drug dosing considerations in alternative hemodialysis.
Decker BS; Mueller BA; Sowinski KM
Adv Chronic Kidney Dis; 2007 Jul; 14(3):e17-26. PubMed ID: 17603971
[TBL] [Abstract][Full Text] [Related]
48. Pilot study to assess increased dialysis efficiency in patients with limited blood flow rates due to vascular access problems.
Mandolfo S; Borlandelli S; Imbasciati E; Badalamenti S; Graziani G; Sereni L; Varesani M; Wratten ML; Corsi A; Elli A
Hemodial Int; 2008 Jan; 12(1):55-61. PubMed ID: 18271842
[TBL] [Abstract][Full Text] [Related]
49. Treatment time, chronic inflammation, and hemodynamic stability: the overlooked parameters in hemodialysis quantification.
Zsom L; Zsom M; Fulop T; Flessner MF
Semin Dial; 2008; 21(5):395-400. PubMed ID: 18945325
[TBL] [Abstract][Full Text] [Related]
50. Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney.
Smeby LC; Jörstad S; Wideröe TE; Svartaas TM
Artif Organs; 1981; 4 Suppl():104-9. PubMed ID: 7295075
[TBL] [Abstract][Full Text] [Related]
51. Dialysis membranes for blood purification.
Sakai K
Front Med Biol Eng; 2000; 10(2):117-29. PubMed ID: 10898241
[TBL] [Abstract][Full Text] [Related]
52. Rethinking the peritoneal dialysis prescription: results of recent studies.
Bargman JM
Nephrology (Carlton); 2006 Apr; 11(2):85-9. PubMed ID: 16669966
[TBL] [Abstract][Full Text] [Related]
53. Serum free-light chain removal by high cutoff hemodialysis: optimizing removal and supportive care.
Hutchison CA; Harding S; Mead G; Goehl H; Storr M; Bradwell A; Cockwell P
Artif Organs; 2008 Dec; 32(12):910-7. PubMed ID: 19133018
[TBL] [Abstract][Full Text] [Related]
54. Efficiency of the Genius batch hemodialysis system with low serum solute concentrations: the case of lithium intoxication therapy.
Dhondt A; Verstraete A; Vandewoude K; Segers H; Eloot S; Decruyenaere J; Vanholder R
Am J Kidney Dis; 2005 Nov; 46(5):e95-9. PubMed ID: 16253717
[TBL] [Abstract][Full Text] [Related]
55. The effect of increasing dialysis dose in overweight hemodialysis patients on quality of life: a 6-week randomized crossover trial.
Wang W; Tonelli M; Hemmelgarn B; Gao S; Johnson JA; Taub K; Manns B;
Am J Kidney Dis; 2008 May; 51(5):796-803. PubMed ID: 18436090
[TBL] [Abstract][Full Text] [Related]
56. Metabolic and hemodynamic advantages of an acetate-free citrate dialysate in a uremic case of congenital methylmalonic acidemia.
Saito T; Saito O; Maeda T; Ito C; Ando Y; Yamagata T; Muto S; Momoi M; Kusano E
Am J Kidney Dis; 2009 Oct; 54(4):764-9. PubMed ID: 19577350
[No Abstract] [Full Text] [Related]
57. Personal daily dialysis: the evolution of the artificial kidney.
Kim JC; Ronco C
Blood Purif; 2013; 36(1):47-51. PubMed ID: 23735654
[TBL] [Abstract][Full Text] [Related]
58. Improving hollow fiber dialyzer efficiency with a recirculating dialysate system. I: Theory and applicability.
Prado M; Roa LM; Palma A; Milán JA
Ann Biomed Eng; 2005 May; 33(5):642-55. PubMed ID: 15981864
[TBL] [Abstract][Full Text] [Related]
59. In vitro assessment of mixed matrix hemodialysis membrane for achieving endotoxin-free dialysate combined with high removal of uremic toxins from human plasma.
Geremia I; Bansal R; Stamatialis D
Acta Biomater; 2019 May; 90():100-111. PubMed ID: 30953798
[TBL] [Abstract][Full Text] [Related]
60. [Quantifying dialysis efficiency for middle molecules in haemodialysis and in convective and mixed techniques].
Casino FG; Lopez T
G Ital Nefrol; 2008; 25(1):66-75. PubMed ID: 18264920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
